*  Whole Health Source: Hyperphagia
I suspect that wheat, sugar and perhaps other processed foods cause hyperphagia. I believe hyperphagia is at least partially ... So why are we eating more? I believe that our increased food intake, or hyperphagia, is the result of metabolic disturbances, ... Leptin resistance leads to hyperphagia, overweight and the metabolic syndrome (a common cluster of symptoms that implies ...
  http://wholehealthsource.blogspot.com/2008/08/hyperphagy.html?showComment=1218412980000
*  Assessment of hyperphagia in Prader-Willi syndrome.
... and hyperphagia. Although complications of obesity resulting from hyperphagia are ... DISCUSSION: The Hyperphagia Questionnaire is a robust tool for relating breakthroughs in the neurobiology of hyperphagia to in ... and hyperphagia. Although complications of obesity resulting from hyperphagia are the leading cause of death in PWS, ... Hyperphagia / epidemiology*. Male. Middle Aged. Motivation. Obesity / epidemiology*. Prader-Willi Syndrome / genetics, ...
  http://www.biomedsearch.com/nih/Assessment-hyperphagia-in-Prader-Willi/17636101.html
*  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. - PubMed - NCBI
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats.. Obici S1, Feng Z, Karkanias G, ... This selective decrease in hypothalamic insulin receptor protein was accompanied by rapid onset of hyperphagia and increased ...
  https://www.ncbi.nlm.nih.gov/pubmed/12021765?dopt=Abstract
*  SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. - PubMed - NCBI
SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice.. Ding F1, Li HH, Zhang S, Solomon NM ... Around three months of age, they develop hyperphagia, but stay lean on regular and high-fat diet. On reduced caloric intake, ... SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice ... SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice ...
  https://www.ncbi.nlm.nih.gov/pubmed/18320030
*  Dysfunction of intraflagellar transport-A causes hyperphagia-induced obesity and metabolic syndrome | Disease Models &...
Hyperphagia is a primary cause of obesity in Thm1-cko mice. (A) Pair-fed WT and Thm1-cko mice 13 weeks post-tamoxifen injection ... To determine whether hyperphagia caused the Thm1-cko weight gain, we pair-fed control and Thm1-cko mice for 13 weeks following ... 4A-C), suggesting hyperphagia is a main contributor to the Thm1-cko obese phenotype. At the 13-week time point, we noted that ... This POMC reduction is likely a main cause of the hyperphagia. POMC-derived peptides attenuate food-seeking behavior and POMC- ...
  http://dmm.biologists.org/content/9/7/789
*  Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function | Journal of...
Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function. Jason G. ... Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function ... Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function ... Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function ...
  http://www.jneurosci.org/content/31/10/3904
*  Repletion of TNFα or leptin in calorically restricted mice suppresses post-restriction hyperphagia | Disease Models & Mechanisms
The causes of post-restriction hyperphagia (PRH) represent a target for drug-based therapies to prevent obesity. However, the ... Repletion of TNFα or leptin in calorically restricted mice suppresses post-restriction hyperphagia ... Repletion of TNFα or leptin in calorically restricted mice suppresses post-restriction hyperphagia ... Repletion of TNFα or leptin in calorically restricted mice suppresses post-restriction hyperphagia ...
  http://dmm.biologists.org/content/early/2011/09/23/dmm.007781
*  Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the...
Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the ... Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the ... Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the ... Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the ...
  http://diabetes.diabetesjournals.org/content/55/12/3366
*  Evidence Supporting a Role for Constitutive Ghrelin Receptor Signaling in Fasting-Induced Hyperphagia in Male Mice,...
"Evidence Supporting a Role for Constitutive Ghrelin Receptor Signaling in Fasting-Induced Hyperphagia in Male Mice, ... smaller hyperphagia, compared with WT mice. Finally, fasting-induced hyperphagia of WT mice was significantly smaller in mice ... smaller hyperphagia, compared with WT mice. Finally, fasting-induced hyperphagia of WT mice was significantly smaller in mice ... Thus, the compensatory hyperphagia seems to depend on homeostatic aspects of feeding, which drive food intake according to ...
  https://www.deepdyve.com/lp/ou_press/evidence-supporting-a-role-for-constitutive-ghrelin-receptor-signaling-Jw39Ygw8ef
*  Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Hyperphagia in Prader-Willi Syndrome -...
"Importantly, it covers the treatment of hyperphagia, one of the highest priority unmet needs in PWS, and the primary endpoint ... Hyperphagia can lead to significant morbidities (i.e., stomach rupture, obesity, diabetes, cardiovascular disease) and ... In the PWS pilot study, DCCR showed promise in addressing the hallmark symptoms of PWS, most notably hyperphagia. DCCR has ... Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Hyperphagia in Prader-Willi Syndrome. ...
  https://stockguru.com/2017/10/11/soleno-therapeutics-announces-issuance-of-new-u-s-patent-for-dccr-covering-treatment-of-hyperphagia-in-prader-willi-syndrome/
*  Q&A: The Dogs Today Think Tank: Treatment for hyperphagia
I have just found out that hyperphagia can accompany Lafora disease. Is there any treatment for hyperphagia or Lafora?. Thank ... Hyperphagia is not a term commonly used in the UK. Your reference to American pounds leads me to suspect you are American and ... My 11-year-old neutered Maltese male has developed hyperphagia. He has gained 1.4 lb (American pounds), from 9.2 to 10.6 lb.in ... it may be that the term 'hyperphagia' is used that side of the pond for what we would call polyphagia, or increased appetite. ...
  http://dogstodaythinktank.blogspot.com/2011/06/treatment-for-hyperphagia.html
*  Medical Issues A-Z
Hunger / Appetite / Hyperphagia (excessive appetite). Hunger (which starts after infancy) is a hallmark of the disorder; there ... Besides the hyperphagia, (uncontrollable drive to eat)children with PWS process calories more slowly than the general ... and the second stage exhibiting hyperphagia (an uncontrollable drive to eat) combined with weight gain on fewer calories. ...
  https://www.pwsausa.org/medical-issues-a-z/
*  Frontiers | Obesity in the Otsuka Long Evans Tokushima Fatty Rat: Mechanisms and Discoveries | Nutrition
... resulting in hyperphagia. Prior to becoming obese and in response to pair feeding, OLETF rats have increased expression of ... resulting in hyperphagia. Prior to becoming obese and in response to pair feeding, OLETF rats have increased expression of ... Characterization of the Hyperphagia in OLETF Rats. The initial discovery that OLETF rats had a deletion in the gene for the CCK ... A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul ...
  https://www.frontiersin.org/articles/10.3389/fnut.2016.00021/full
*  ROHHAD - Wikipedia
The variable presentation of ROHHAD includes the following main symptoms: Hyperphagia and obesity by age of 10 years - (median ... Hyperphagia; Diabetes insipidus; Ophthalmologic Manifestations; Thermal Dysregulation; Gastrointestinal dysmotility; Altered ...
  https://en.wikipedia.org/wiki/ROHHAD
*  Guide for authors - Environmental Toxicology and Pharmacology - ISSN 1382-6689
First category key-words (e.g. Hyperphagia; G-Strophantidin; Fiber shortening) will all be listed and cross-indexed. Second ...
  https://www.elsevier.com/journals/environmental-toxicology-and-pharmacology/1382-6689/guide-for-authors
*  Pathology Flashcards by Nicole Fernandez | Brainscape
Brainscape is a web and mobile study platform that helps you learn things faster. Our mission is to create a smarter world by simplifying and accelerating the learning process. © 2018 Bold Learning Solutions ...
  https://www.brainscape.com/flashcards/pathology-1036317/packs/1914933
*  Guided Self-help for Binge Eating - Full Text View - ClinicalTrials.gov
Guided self-help (GSH) is a recommended first-step treatment for bulimia nervosa, binge eating disorder, and atypical variants of these disorders. The current study proposes to investigate the effectiveness of providing GSH either face-to-face or via e-mail, also using a delayed treatment control condition. Symptom outcomes will be assessed, and an estimate of cost-effectiveness made. Results are proposed to be disseminated locally and internationally (through submission to conferences and peer-reviewed journals), and will hopefully inform local service provision.. Please note that we are only able to offer the intervention to individuals who are currently registered with a General Practitioner that is covered by Oxford Health NHS Foundation Trust - this is typically restricted to practices in Oxfordshire, Buckinghamshire, and parts of Wiltshire. ...
  https://clinicaltrials.gov/ct2/show/NCT01832792?recr=Open&cond=%22Eating+Disorders%22&rank=15
*  Online Cognitive Behavioral Therapy for Bulimia Nervosa - Full Text View - ClinicalTrials.gov
Hyperphagia. Signs and Symptoms, Digestive. Signs and Symptoms. Feeding and Eating Disorders. Mental Disorders. ...
  https://clinicaltrials.gov/ct2/show/NCT00877786
*  An Integrative Intervention for Loss of Control Eating Among Adolescent Girls - Full Text View - ClinicalTrials.gov
Hyperphagia. Signs and Symptoms, Digestive. Signs and Symptoms. Feeding and Eating Disorders. Mental Disorders. ...
  https://clinicaltrials.gov/ct2/show/NCT01395355
*  Motivating Factors That Play a Role in Bulimia Nervosa - Full Text View - ClinicalTrials.gov
Bulimia nervosa (BN) is a serious eating disorder that is characterized by frequent uncontrolled eating binges. These binges are often followed by compensatory behavior, including the following: self-induced vomiting; misuse of laxatives, diuretics, enemas, or other medications to induce purging; fasting; or excessive exercise. If left untreated, BN can lead to many serious health issues: tooth decay; irregular menstruation; bowel damage; constipation; heart and kidney disease; intestinal damage; puffiness, especially in the face and fingers; increased hair growth on the face and body; and mineral imbalances in the body. Similar to drug abuse disorders, food-related thinking and disordered eating behavior can interfere with other occupational and social activities, as well. This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.. Interested ...
  https://clinicaltrials.gov/ct/show/NCT00304174
*  An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa - Full Text View - ClinicalTrials.gov
Patients with Bulimia Nervosa (BN) have difficulty regulating impulsive behaviors as suggested by their binge-eating and purging, as well as the high incidence of drug abuse and shoplifting in this population. Understanding dysfunction in the frontostriatal circuitry that mediates self-regulatory control processes will aid development of new therapeutics for the impulsivity associated with BN. We are conducting a longitudinal study to better understand the development and persistence of BN.. Participation in this study includes 4 sections: Neuropsychological Tests, Diagnostic interviews, Pregnancy Test, and MRI scan. All efforts are made to coordinate procedures into one day, and they require between 4 and 5 hours of the participant's time. The option of splitting participation into two study days is also offered for participants who find it more convenient. Participants are compensated with $100 in the form of a check, which is mailed to their home address. Participants will be invited back for ...
  https://clinicaltrials.gov/ct2/show/NCT00345943?term=%22Mitral+Valve+Regurgitation%22&lup_s=02%2F11%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity - Full Text View - ClinicalTrials.gov
Hyperphagia. Signs and Symptoms, Digestive. Lamotrigine. Anticonvulsants. Calcium Channel Blockers. Membrane Transport ...
  https://clinicaltrials.gov/show/NCT00277641
*  How Does 4 Weeks of Increased Fast Food Intake Affect Metabolism? - Full Text View - ClinicalTrials.gov
Objective: To study the effect of fast food-based hyper-alimentation on liver enzymes and hepatic triglyceride content (HTGC)and metabolism.. Design: Prospective interventional study with parallel control group. Setting University Hospital of Linköping, Sweden. Participants: 12 healthy men and six healthy women with a mean (SD) age of 26 (6.6) years and a matched control group.. Intervention: Subjects in the intervention group aimed for a body weight increase of 5-15% by eating at least two fast food-based meals a day with the goal to double the regular caloric intake in combination with adoption of a sedentary lifestyle for four weeks.. Main outcome measures: Weekly changes of serum aminotransferases and HTGC measured by proton nuclear magnetic resonance-spectroscopy at baseline and after the intervention. ...
  https://clinicaltrials.gov/ct2/show/NCT00826631